{"id":"https://openalex.org/W4293752108","doi":"https://doi.org/10.1039/d2cc03052g","title":"A pH-responsive crosslinker platform for antibody-drug conjugate (ADC) targeting delivery","display_name":"A pH-responsive crosslinker platform for antibody-drug conjugate (ADC) targeting delivery","publication_year":2022,"publication_date":"2022-01-01","ids":{"openalex":"https://openalex.org/W4293752108","doi":"https://doi.org/10.1039/d2cc03052g","pmid":"https://pubmed.ncbi.nlm.nih.gov/36043993"},"language":"en","primary_location":{"id":"doi:10.1039/d2cc03052g","doi":"https://doi.org/10.1039/d2cc03052g","is_oa":true,"landing_page_url":"https://doi.org/10.1039/d2cc03052g","pdf_url":"https://pubs.rsc.org/en/content/articlepdf/2022/cc/d2cc03052g","source":{"id":"https://openalex.org/S152760256","display_name":"Chemical Communications","issn_l":"1359-7345","issn":["1359-7345","1364-548X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-2","ki-jl-1","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320556","host_organization_name":"Royal Society of Chemistry","host_organization_lineage":["https://openalex.org/P4310320556"],"host_organization_lineage_names":["Royal Society of Chemistry"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chemical Communications","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://pubs.rsc.org/en/content/articlepdf/2022/cc/d2cc03052g","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052169810","display_name":"Francesca Migliorini","orcid":"https://orcid.org/0000-0003-2149-978X","observed_orcids":["https://orcid.org/0000-0003-2149-978X"]},"institutions":[{"id":"https://openalex.org/I102064193","display_name":"University of Siena","ror":"https://ror.org/01tevnk56","country_code":"IT","type":"education","lineage":["https://openalex.org/I102064193"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Francesca Migliorini","raw_affiliation_strings":["Dipartimento di Biotecnologie, Chimica e Farmacia, Universit\u00e0 degli Studi di Siena, Via A.Moro 2, 53100 Siena, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Biotecnologie, Chimica e Farmacia, Universit\u00e0 degli Studi di Siena, Via A.Moro 2, 53100 Siena, Italy","institution_ids":["https://openalex.org/I102064193"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001758695","display_name":"Elena Cini","orcid":"https://orcid.org/0000-0003-4420-8930","observed_orcids":["https://orcid.org/0000-0003-4420-8930"]},"institutions":[{"id":"https://openalex.org/I102064193","display_name":"University of Siena","ror":"https://ror.org/01tevnk56","country_code":"IT","type":"education","lineage":["https://openalex.org/I102064193"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Elena Cini","raw_affiliation_strings":["Dipartimento di Biotecnologie, Chimica e Farmacia, Universit\u00e0 degli Studi di Siena, Via A.Moro 2, 53100 Siena, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Biotecnologie, Chimica e Farmacia, Universit\u00e0 degli Studi di Siena, Via A.Moro 2, 53100 Siena, Italy","institution_ids":["https://openalex.org/I102064193"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090835353","display_name":"Elena Dreassi","orcid":"https://orcid.org/0000-0001-8987-940X","observed_orcids":["https://orcid.org/0000-0001-8987-940X"]},"institutions":[{"id":"https://openalex.org/I102064193","display_name":"University of Siena","ror":"https://ror.org/01tevnk56","country_code":"IT","type":"education","lineage":["https://openalex.org/I102064193"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Elena Dreassi","raw_affiliation_strings":["Dipartimento di Biotecnologie, Chimica e Farmacia, Universit\u00e0 degli Studi di Siena, Via A.Moro 2, 53100 Siena, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Biotecnologie, Chimica e Farmacia, Universit\u00e0 degli Studi di Siena, Via A.Moro 2, 53100 Siena, Italy","institution_ids":["https://openalex.org/I102064193"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008949930","display_name":"Federica Finetti","orcid":"https://orcid.org/0000-0003-1144-3360","observed_orcids":["https://orcid.org/0000-0003-1144-3360"]},"institutions":[{"id":"https://openalex.org/I102064193","display_name":"University of Siena","ror":"https://ror.org/01tevnk56","country_code":"IT","type":"education","lineage":["https://openalex.org/I102064193"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Federica Finetti","raw_affiliation_strings":["Dipartimento di Biotecnologie, Chimica e Farmacia, Universit\u00e0 degli Studi di Siena, Via A.Moro 2, 53100 Siena, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Biotecnologie, Chimica e Farmacia, Universit\u00e0 degli Studi di Siena, Via A.Moro 2, 53100 Siena, Italy","institution_ids":["https://openalex.org/I102064193"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082422571","display_name":"Giovanni Ievoli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102064193","display_name":"University of Siena","ror":"https://ror.org/01tevnk56","country_code":"IT","type":"education","lineage":["https://openalex.org/I102064193"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giovanni Ievoli","raw_affiliation_strings":["Dipartimento di Biotecnologie, Chimica e Farmacia, Universit\u00e0 degli Studi di Siena, Via A.Moro 2, 53100 Siena, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Biotecnologie, Chimica e Farmacia, Universit\u00e0 degli Studi di Siena, Via A.Moro 2, 53100 Siena, Italy","institution_ids":["https://openalex.org/I102064193"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Giulia Macr\u00ec","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102064193","display_name":"University of Siena","ror":"https://ror.org/01tevnk56","country_code":"IT","type":"education","lineage":["https://openalex.org/I102064193"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giulia Macr\u00ec","raw_affiliation_strings":["Dipartimento di Biotecnologie, Chimica e Farmacia, Universit\u00e0 degli Studi di Siena, Via A.Moro 2, 53100 Siena, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Biotecnologie, Chimica e Farmacia, Universit\u00e0 degli Studi di Siena, Via A.Moro 2, 53100 Siena, Italy","institution_ids":["https://openalex.org/I102064193"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005793362","display_name":"Elena Petricci","orcid":"https://orcid.org/0000-0002-9685-6342","observed_orcids":["https://orcid.org/0000-0002-9685-6342"]},"institutions":[{"id":"https://openalex.org/I102064193","display_name":"University of Siena","ror":"https://ror.org/01tevnk56","country_code":"IT","type":"education","lineage":["https://openalex.org/I102064193"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Elena Petricci","raw_affiliation_strings":["Dipartimento di Biotecnologie, Chimica e Farmacia, Universit\u00e0 degli Studi di Siena, Via A.Moro 2, 53100 Siena, Italy"],"raw_orcid":"https://orcid.org/0000-0002-9685-6342","affiliations":[{"raw_affiliation_string":"Dipartimento di Biotecnologie, Chimica e Farmacia, Universit\u00e0 degli Studi di Siena, Via A.Moro 2, 53100 Siena, Italy","institution_ids":["https://openalex.org/I102064193"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010151639","display_name":"Enrico Rango","orcid":"https://orcid.org/0000-0001-6509-136X","observed_orcids":["https://orcid.org/0000-0001-6509-136X"]},"institutions":[{"id":"https://openalex.org/I102064193","display_name":"University of Siena","ror":"https://ror.org/01tevnk56","country_code":"IT","type":"education","lineage":["https://openalex.org/I102064193"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Enrico Rango","raw_affiliation_strings":["Dipartimento di Biotecnologie, Chimica e Farmacia, Universit\u00e0 degli Studi di Siena, Via A.Moro 2, 53100 Siena, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Biotecnologie, Chimica e Farmacia, Universit\u00e0 degli Studi di Siena, Via A.Moro 2, 53100 Siena, Italy","institution_ids":["https://openalex.org/I102064193"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028660705","display_name":"Lorenza Trabalzini","orcid":"https://orcid.org/0000-0002-0850-7186","observed_orcids":["https://orcid.org/0000-0002-0850-7186","https://orcid.org/0000-0001-6363-6485"]},"institutions":[{"id":"https://openalex.org/I102064193","display_name":"University of Siena","ror":"https://ror.org/01tevnk56","country_code":"IT","type":"education","lineage":["https://openalex.org/I102064193"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Lorenza Trabalzini","raw_affiliation_strings":["Dipartimento di Biotecnologie, Chimica e Farmacia, Universit\u00e0 degli Studi di Siena, Via A.Moro 2, 53100 Siena, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Biotecnologie, Chimica e Farmacia, Universit\u00e0 degli Studi di Siena, Via A.Moro 2, 53100 Siena, Italy","institution_ids":["https://openalex.org/I102064193"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076377697","display_name":"Maurizio Taddei","orcid":"https://orcid.org/0000-0001-8660-7580","observed_orcids":["https://orcid.org/0000-0001-8660-7580"]},"institutions":[{"id":"https://openalex.org/I102064193","display_name":"University of Siena","ror":"https://ror.org/01tevnk56","country_code":"IT","type":"education","lineage":["https://openalex.org/I102064193"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Maurizio Taddei","raw_affiliation_strings":["Dipartimento di Biotecnologie, Chimica e Farmacia, Universit\u00e0 degli Studi di Siena, Via A.Moro 2, 53100 Siena, Italy"],"raw_orcid":"https://orcid.org/0000-0001-8660-7580","affiliations":[{"raw_affiliation_string":"Dipartimento di Biotecnologie, Chimica e Farmacia, Universit\u00e0 degli Studi di Siena, Via A.Moro 2, 53100 Siena, Italy","institution_ids":["https://openalex.org/I102064193"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5076377697"],"corresponding_institution_ids":["https://openalex.org/I102064193"],"apc_list":null,"apc_paid":null,"fwci":1.1512,"has_fulltext":true,"cited_by_count":27,"citation_normalized_percentile":{"value":0.71548048,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":98,"max":99},"biblio":{"volume":"58","issue":"75","first_page":"10532","last_page":"10535"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.45239999890327454,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.45239999890327454,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.13449999690055847,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11440","display_name":"Click Chemistry and Applications","score":0.09239999949932098,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9829999804496765},{"id":"https://openalex.org/keywords/self-immolative-linker","display_name":"self-immolative linker","score":0.9129999876022339},{"id":"https://openalex.org/keywords/gallic-acid-derivatives","display_name":"gallic acid derivatives","score":0.9490000009536743},{"id":"https://openalex.org/keywords/drug-release","display_name":"drug release","score":0.6010000109672546},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.8339999914169312},{"id":"https://openalex.org/keywords/combretastatin-a-4","display_name":"combretastatin A-4","score":0.9959999918937683},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.996999979019165},{"id":"https://openalex.org/keywords/targeted-drug-delivery","display_name":"targeted drug delivery","score":0.7129999995231628},{"id":"https://openalex.org/keywords/cancer-cell-viability","display_name":"tumor cell viability","score":0.5389999747276306}],"concepts":[{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.881904661655426},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.7265381813049316},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.6472102999687195},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6180738210678101},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.5637907981872559},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5180487632751465},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4470434784889221},{"id":"https://openalex.org/C126511603","wikidata":"https://www.wikidata.org/wiki/Q1261145","display_name":"Targeted drug delivery","level":3,"score":0.4129476249217987},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3710440397262573},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.20293346047401428},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.18543696403503418},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.1224515438079834},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.11065813899040222},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.10755422711372375},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068818","descriptor_name":"Cetuximab","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001688","descriptor_name":"Biological Products","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005707","descriptor_name":"Gallic Acid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006863","descriptor_name":"Hydrogen-Ion Concentration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011748","descriptor_name":"Pyrogallol","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1039/d2cc03052g","doi":"https://doi.org/10.1039/d2cc03052g","is_oa":true,"landing_page_url":"https://doi.org/10.1039/d2cc03052g","pdf_url":"https://pubs.rsc.org/en/content/articlepdf/2022/cc/d2cc03052g","source":{"id":"https://openalex.org/S152760256","display_name":"Chemical Communications","issn_l":"1359-7345","issn":["1359-7345","1364-548X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-2","ki-jl-1","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320556","host_organization_name":"Royal Society of Chemistry","host_organization_lineage":["https://openalex.org/P4310320556"],"host_organization_lineage_names":["Royal Society of Chemistry"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chemical Communications","raw_type":"journal-article"},{"id":"pmid:36043993","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36043993","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chemical communications (Cambridge, England)","raw_type":"Journal Article"},{"id":"pmh:oai:usiena-air.unisi.it:11365/1218737","doi":null,"is_oa":true,"landing_page_url":"https://hdl.handle.net/11365/1218737","pdf_url":null,"source":{"id":"https://openalex.org/S4377196319","display_name":"Use Siena air (University of Siena)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I102064193","host_organization_name":"University of Siena","host_organization_lineage":["https://openalex.org/I102064193"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1039/d2cc03052g","doi":"https://doi.org/10.1039/d2cc03052g","is_oa":true,"landing_page_url":"https://doi.org/10.1039/d2cc03052g","pdf_url":"https://pubs.rsc.org/en/content/articlepdf/2022/cc/d2cc03052g","source":{"id":"https://openalex.org/S152760256","display_name":"Chemical Communications","issn_l":"1359-7345","issn":["1359-7345","1364-548X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-2","ki-jl-1","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320556","host_organization_name":"Royal Society of Chemistry","host_organization_lineage":["https://openalex.org/P4310320556"],"host_organization_lineage_names":["Royal Society of Chemistry"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chemical Communications","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.5683000087738037,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G867695943","display_name":null,"funder_award_id":"IG 2017 \u2013 ID. 20758 project \u2013 P.I. Taddei Maur","funder_id":"https://openalex.org/F4320323054","funder_display_name":"Associazione Italiana per la Ricerca sul Cancro"}],"funders":[{"id":"https://openalex.org/F4320323054","display_name":"Associazione Italiana per la Ricerca sul Cancro","ror":"https://ror.org/02g2x7380"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4293752108.pdf","grobid_xml":"https://content.openalex.org/works/W4293752108.grobid-xml"},"referenced_works_count":35,"referenced_works":["https://openalex.org/W1945627170","https://openalex.org/W2000285060","https://openalex.org/W2023863818","https://openalex.org/W2028748400","https://openalex.org/W2054032438","https://openalex.org/W2072489670","https://openalex.org/W2147000598","https://openalex.org/W2165168809","https://openalex.org/W2167795547","https://openalex.org/W2193821265","https://openalex.org/W2272264121","https://openalex.org/W2346771703","https://openalex.org/W2412305372","https://openalex.org/W2531611585","https://openalex.org/W2597045666","https://openalex.org/W2754071011","https://openalex.org/W2767057557","https://openalex.org/W2767148965","https://openalex.org/W2783268592","https://openalex.org/W2806683929","https://openalex.org/W2883873335","https://openalex.org/W2938537124","https://openalex.org/W2958576566","https://openalex.org/W2959179512","https://openalex.org/W2968014280","https://openalex.org/W3009586897","https://openalex.org/W3022730024","https://openalex.org/W3049245512","https://openalex.org/W3072592197","https://openalex.org/W3083440084","https://openalex.org/W3088627973","https://openalex.org/W3126028722","https://openalex.org/W3156822569","https://openalex.org/W3159489770","https://openalex.org/W3176164161"],"related_works":["https://openalex.org/W3112601229","https://openalex.org/W4205877584","https://openalex.org/W7124837787","https://openalex.org/W3152978162","https://openalex.org/W2034903375","https://openalex.org/W2098295005","https://openalex.org/W4410873657","https://openalex.org/W4411088958","https://openalex.org/W2118804904","https://openalex.org/W1910013341"],"abstract_inverted_index":{"We":[0],"report":[1],"a":[2,19],"new":[3],"1-6":[4],"self-immolative,":[5],"traceless":[6],"crosslinker":[7],"derived":[8],"from":[9],"the":[10,49,66],"natural":[11],"product":[12],"gallic":[13],"acid.":[14],"The":[15,58,76],"linker":[16,59],"acts":[17],"through":[18],"pH-dependent":[20],"mechanism":[21],"for":[22,32,65],"drug":[23],"release.":[24],"This":[25],"5-(hydroxymethyl)pyrogallol":[26],"orthoester":[27],"derivative":[28],"(HMPO)":[29],"was":[30,60,63],"stable":[31],"24":[33],"hours":[34],"at":[35,55],"pH":[36,56,81],"values":[37],"of":[38,68,86],"7.4":[39],"and":[40,42,62,88],"6.6":[41],"in":[43],"plasma,":[44],"releasing":[45],"molecules":[46],"bound":[47],"to":[48],"hydroxymethyl":[50],"moiety":[51],"under":[52],"acid-dependent":[53],"stimuli":[54],"5.5.":[57],"non-toxic":[61],"used":[64],"conjugation":[67],"Doxorubicin":[69],"(Doxo)":[70],"or":[71],"Combretastatin":[72],"A4":[73],"with":[74],"Cetuximab.":[75],"ADCs":[77],"formed":[78],"showed":[79],"their":[80],"responsivity":[82],"reducing":[83],"cell":[84],"viability":[85],"A431":[87],"A549":[89],"cancer":[90],"cells":[91],"better":[92],"than":[93],"Cetuximab":[94],"alone.":[95]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":7}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2022-08-31T00:00:00"}